R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize

Tzu-Ping Lin1,2,3,4, Jingjing Li5, Qinlong Li6,7

  • 1Depatment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California.

Insights

Researchers discovered that elevated R1 protein levels in prostate cancer correlate with worse outcomes. R1 (CDCA7L) promotes tumor growth by stabilizing the c-Myc oncoprotein, suggesting R1 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer poses a significant global health challenge, necessitating novel therapeutic strategies.
  • Identifying new molecular targets is crucial for improving patient outcomes and quality of life.

Purpose of the Study:

  • To investigate the role of R1 (CDCA7L), a c-Myc-interacting protein, in prostate cancer pathogenesis.
  • To explore R1 as a potential therapeutic and prognostic marker for prostate cancer.

Main Methods:

  • Analysis of R1 expression in human prostate cancer tissues and correlation with clinical data.
  • In vitro studies involving R1 overexpression and knockdown in prostate cancer cell lines.
  • In vivo experiments using prostate tumor xenografts in mice.
  • Mechanistic studies to elucidate R1's effect on c-Myc stability and HUWE1 expression.

Main Results:

  • R1 expression is elevated in prostate cancer tissues and associated with disease recurrence and reduced patient survival.
  • R1 overexpression enhances prostate cancer cell proliferation and colony formation.
  • Silencing R1 significantly inhibits prostate tumor xenograft growth in mice.
  • R1 stabilizes c-Myc by transcriptionally suppressing HUWE1, a c-Myc-targeting E3 ligase.

Conclusions:

  • R1 is a novel regulator of prostate tumor growth, acting by increasing c-Myc protein stability.
  • These findings highlight R1's potential as a therapeutic target and prognostic biomarker in prostate cancer.
  • Further research into R1's therapeutic and prognostic potential is warranted.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Master Transcription Regulators02:23

Master Transcription Regulators

2.8K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.6K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K